Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Preferred Dividend Payments for 2 consecutive years, with $11.0 million as the latest value for Q1 2020.

  • Quarterly Preferred Dividend Payments changed N/A to $11.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Mar 2021, down 39.28% year-over-year, with the annual reading at -$6.2 million for FY2019, N/A changed from the prior year.
  • Preferred Dividend Payments for Q1 2020 was $11.0 million at Pliant Therapeutics, up from -$10.3 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $11.0 million in Q1 2020, with the low at -$10.3 million in Q4 2019.